Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HOB Biotech GroupSHSE:688656 -1.14%87 5-Year Yield-on-Cost % is 0.23 as of Aug. 06, 2026, which is 68% below its 10-year median of 0.73. GuruFocus rates SHSE:688656 with a GF Score™ of 87/100 and a GF Value™ of ¥90.55 (Fairly Valued). The stock has 8 warning signs investors should review. Among 317 Medical Devices & Instruments companies, HOB Biotech Group ranks worse than 95.58% on this metric.
HOB Biotech Group's yield on cost for the quarter that ended in Mar. 2026 was 0.23.
The historical rank and industry rank for HOB Biotech Group's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688656'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15 Med: 0.73 Max: 2
Current: 0.23
During the past 10 years, HOB Biotech Group's highest Yield on Cost was 2.00. The lowest was 0.15. And the median was 0.73.
SHSE:688656's 5-Year Yield-on-Cost % is ranked worse than 95.58% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 2.41
vs SHSE:688656: 0.23
HOB Biotech Group (SHSE:688656) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
HOB Biotech Group 5-Year Yield-on-Cost % Related Terms
SHSE:688656 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, HOB Biotech Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HOB Biotech Group 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where HOB Biotech Group's 5-Year Yield-on-Cost % falls into.
HOB Biotech Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
HOB Biotech Group (SHSE:688656) has a 5-Year Yield-on-Cost % of 0.23 as of Aug. 06, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on HOB Biotech Group and its competitors. This is 68% below median its historical median of 0.73. Over the past decade, HOB Biotech Group's 5-Year Yield-on-Cost % has ranged from 0.15 to 2.00. According to the industry distribution chart, HOB Biotech Group ranks #303 out of 317 companies in the Medical Devices & Instruments industry, placing it in the top 95.6%.
Is HOB Biotech Group's 5-Year Yield-on-Cost % too high?
HOB Biotech Group's current 5-Year Yield-on-Cost % of 0.23 is 68% below median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 2.00. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.41. HOB Biotech Group's value of 0.23 is 90.5% below this industry median. Based on the distribution chart, HOB Biotech Group ranks #303 out of 317 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, HOB Biotech Group has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HOB Biotech Group's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HOB Biotech Group ranks #303 out of 317 companies for 5-Year Yield-on-Cost %. This places HOB Biotech Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.41. HOB Biotech Group's value of 0.23 is 90.5% below this benchmark. Historically, HOB Biotech Group's own 5-Year Yield-on-Cost % has ranged from 0.15 to 2.00 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 2.41, HOB Biotech Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.41, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HOB Biotech Group's current 5-Year Yield-on-Cost % of 0.23 is 90.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on HOB Biotech Group and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HOB Biotech Group's current 5-Year Yield-on-Cost % is 0.23, which is 68% below median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOB Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, HOB Biotech Group (SHSE:688656) is currently considered Fairly Valued. The stock's GF Value™ is ¥90.55, compared to a current price of ¥86.04 — trading 5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.23, which is 68% below median its 10-year median of 0.73 and 90.5% below the Medical Devices & Instruments industry median of 2.41. HOB Biotech Group's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For HOB Biotech Group (SHSE:688656), the current 5-Year Yield-on-Cost % is 0.23 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HOB Biotech Group (SHSE:688656) Overvalued in 2026?
Based on GuruFocus' analysis, HOB Biotech Group stock appears to be undervalued.
The current stock price of ¥86.04 is trading 5% below its estimated GF Value™ of ¥90.55.
GuruFocus considers HOB Biotech Group to be Fairly Valued.
Key valuation signals for SHSE:688656:
5-Year Yield-on-Cost %: 0.23 (68% below median its 10-year median of 0.73)
GF Value™: ¥90.55 vs. price of ¥86.04 (5% below fair value)
Industry Position: 90.5% below the Medical Devices & Instruments median (#303 of 317)
No single metric tells the full story. See the SHSE:688656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
87GF Score
Get the complete analysis for SHSE:688656
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688656 has been successfully added to your 
